The AATB biennial election for the 2021-2023 AATB Board of Governors Officers and At-Large Members is now open.

Please access the PDF below to read the response to the FDA safety communication on March 31, 2021, titled Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction Differ in Complication Rates.

At the 2019 AATB Annual meeting in Toronto, AATB began working with a group of representatives from both recovery only and processing establishments to develop a revised approach to conducting inspections of establishments that perform the singular activity of recovering donated tissue.

AATB’s Physicians Council has shared a slide deck from the Center for Disease Control (CDC) to assist tissue establishment medical directors in educating their organizations’ staff and addressing vaccine hesitancy.

Earlier this month, the FDA announced that they will resume in-person domestic inspections with a new risk assessment system beginning July 20, 2020.

Use of ISBT 128 by North American Tissue Banks | Version 1.4.0

The American Association of Tissue Banks (AATB) Board of Directors today announced the selection of Marc Pearce as its new President and Chief Executive Officer. Pearce will start at AATB on June 1st.

COVID-19 is on everyone's mind with the effects being felt around the world.

In light of the current COVID-19 pandemic and the resultant closures of businesses and non-essential operations by many state governments, AATB would like to emphasize that tissue banks are an essential health care operation.